删除或更新信息,请邮件至freekaoyan#163.com(#换成@)

上海交通大学医学院研究生导师简介 罗全勇

上海交通大学 免费考研网/2013-01-10

基本信息
导师姓名: 罗全勇 专业代码: 100207
性别: 专业名称: 影像医学与核医学
培养单位: 第六人民医院 三级学科/
专业领域:
未设
导师类型: 硕士生导师 专业学位导师:
联系方式: lqyn@sh163.net 地址:上海市宜山路600号上海交通大学附属第六人民医院核医学科,200233办公室电话:021-64369181-8871
研究方向 (点击浏览详细信息)
核医学技术诊断和治疗肿瘤的基础与临床研究
社会任职
《中华临床医师杂质(电子版)》特约审稿专家
中华医学会核医学分会(第八届)青年委员
《上海医学影像》常务编委
《Journal of Nuclear Medicine & Radiation Therapy》编委
中国医学影像技术研究会核医学分会委员
上海医学会核医学分会青年委员
医院特色专业“碘-131治疗甲状腺癌”负责人
上海交通大学附属第六人民医院核医学科 行政副主任
《中华现代影像学杂志》常务编委
国家自然科学基金通讯评阅专家
《Alternative & Integrative Medicine》编委
科研项目
项目编号项目名称课题来源起止时间科研经费承担职责
81201115micro-RNA106a对乳头状甲状腺癌碘-131摄取功能的影响及机制国家自然科学基金2013-01~~2016-1224万元课题参与人
81271611Afamin对分化型甲状腺癌失分化与碘-131摄取功能的影响及机制国家自然科学基金2013-01~~2016-1270万元课题负责人
2010-2013分化型甲状腺癌的碘-131治疗与蛋白质组学研究上海交通大学医学院“新百人计划”2010-01~~2013-1215万元课题负责人
2007-2010131I-SPECT-CT诊断分化型甲状腺癌的临床研究上海交通大学医学院“优秀青年教师”计划2007-06~~2010-063万元课题负责人
06QA1404099mTc-Annexin B1早期探测化疗后肿瘤细胞凋亡的实验研究上海市科委启明星计划2007-01~~2008-1210万元课题负责人
3060015599mTc-Annexin B1早期探测化疗后肿瘤细胞凋亡的实验研究国家自然基金委2007-01~~2009-1223万元课题负责人
044Y05直接标记法制备新型细胞凋亡显像剂99mTc-Annexin B1的研究上海市卫生局2005-1~~2006-122.0万元课题负责人
学术论文 (#为通讯作者,*为共同第一作者)

1、Song HJ, Xu YH, Qiu ZL, Luo QY#. Abnormal Iodine-131 Uptake in a Benign Serous Ovarian Cystadenoma Mimicking Bladder Physiological Uptake.. Clinical Nuclear Medicine,2012;37(3):59-60
2、Song HJ, Xu YH, Qiu ZL, Luo QY#. Percutaneous osteoplasty combined with Radioiodine as a Treatment for Bone Metastases from Differentiated Thyroid Carcinoma.. Clinical Nuclear Medicine,2012;37(6):129-133
3、Xue Yan-Li; Song Hong-Jun; Qiu Zhong-Ling; Luo Quan-Yong. An Unusual 131I-Avid Adrenal Metastasis From Follicular Thyroid Carcinoma Identified by 131I-SPECT/CT. Clinical Nuclear Medicine,2012;37(9):229-230
4、Qiu ZL, Xue YL, Song HJ, Luo QY.#. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.. Nuclear Medicine Communications,2012;33(12):1232-1242
5、Song HJ, Xue YL, Qiu ZL, Luo QY.#. Uncommon metastases from differentiated thyroid carcinoma.. Hell J Nucl Med., 2012;15(3):233-240.
6、Xue YL, Qiu ZL, Song HJ, Luo QY.#. Value of (131)I SPECT/CT for the evaluation of differentiated thyroid cancer: a systematic review of the literature.. Eur J Nucl Med Mol Imaging.,2012;12(12):1-12
7、Xu YH, Song HJ, Qiu ZL, Luo QY.#. 131I-SPECT/CT Found an Ovarian Metastasis Covered by Iliac Metastasis on 131I-WBS in a Patient with Papillary Thyroid Carcinoma.. Clinical Nuclear Medicine,2011;36(2):363–364
8、Xu YH, Song HJ, Qiu ZL, Luo QY.#. Brain metastases with exceptional features from papillary thyroid carcinoma:report of three cases. . Hellenic Journal of Nuclear Madicine,2011;14(1):44-48
9、Song HJ, Xu YH, Qiu ZL, Luo QY. #. Rare Metastases of Differentiated Thyroid Carcinoma: Pictorial review. . Endocrine Related cancer,2011;35(3):165-174
10、Xu YH, Song HJ, Qiu ZL, Luo QY.#. Extensive lymph node metastases found by 18FDG-PET/CT in a patient with diffuse sclerosing variant of papillary thyroid carcinoma: a case report. . Hellenic Journal of Nuclear Medicine,2011;26(2):56-58
11、许艳红, 王文静, 宋红俊, 邱忠领, 罗全勇.. 伴与不伴远处转移乳头状甲状腺癌患者血清的差异蛋白质组学分析及筛选模型的建立 . 中华临床医师杂志,2011;5(3):686-690
12、Qiu ZL, Song HJ, Xu YH, Luo QY.#. Efficacy and survival analysis of 131I therapy for bone metastases from differentiated thyroid cancer. . Journal of Clinical Endocrinology & Metabolism,2011;96(10):3078-3086
13、Xu YH, Song HJ, Qiu ZL, Luo QY.#. Serum differential proteomics analysis between papillary thyroid cancer patients with 131I-avid lung metastases and those with non-131I-avid lung metastases.. Hellenic Journal of Nuclear Medicine,2011;14(3):228-233
14、Qiu ZL, Xu YH, Song HJ, Luo QY.#. Localization and identification of parapharyngeal metastases from differentiated thyroid carcinoma by 131I-SPECT/CT. . Head and Neck,2010;DOI: 10.1002/hed.21416
15、Qiu ZL, Xu YH, Song HJ, Luo QY. #. Unusual 131I Uptake in a Benign Mucinous Cystadenoma of the Ovary in a Patient with Papillary Thyroid Cancer.. Clinical Nuclear Medicine,2010;35(12):965-966
16、Xu YH, Song HJ, Qiu ZL, Luo QY. #. Multiply extraosseous accumulation of 99mTc-MDP in acute lymphocytic leykemia and literature review.. Hellenic Journal Of Nuclear Medicine,2010;13(3):273-276
17、邱忠领 许艳红 宋红俊 陈立波 朱瑞森 陆汉魁 罗全勇. 分化型甲状腺癌的临床特征与影像学诊断分析. 上海交通大学学报(医学版),2010;30(9):1059-1061
18、陈泽泉; 罗全勇; 余永利. 组蛋白乙酰化抑制剂及其在甲状腺癌治疗中的应用 . 肿瘤防治研究,2010;37(2):242-244.
19、Qiu Zhongling, Luo Quanyong#. Coexistant Iodine-negative Pleura Metastasis with Iodine-positive Lung and Bone Metastases in a Same Differentiated Thyroid Cancer Patient.. Clinical Nuclear Medicine,2009;34(11): 836-837
20、Qiu Zhongling, Luo Quanyong.#. Erector Spinae Metastases from Differentiated Thyroid Cancer Identified by 131I-SPECT/CT.. Clinical Nuclear Medicine,2009;2009; 34(3): 137-140.
21、陈泽泉,罗全勇等.#. 儿童及青少年分化型甲状腺癌的临床特征与碘-131治疗分析. 中华核医学杂志,2009;29(3):153-156
22、邱忠领,罗全勇. #. 甲状腺球蛋白与甲状腺癌. . 国际放射医学与核医学杂志,2009;33:89-92.
23、Luo Quanyong#, Wang Fang, Zhang Zhiyong, et al.. Preparation and bioevaluation of 99mTc-HYNIC-annexin B1 as a novel radioligand for apoptosis imaging. Apoptosis,2008;13(4):600-608
24、Luo Quanyong#, Luo Qiong, Chen Libo. Multiple Subdermal Metastases from Papillary Thyroid Cancer.. Thyroid,2008;18(8):907-908
25、Luo Qiong, Luo Quanyong#, Zhu RS, et al. . Localization of Concomitant Metastases to Kidney and Erector Spinae from Papillary Thyroid Carcinoma Using 131I-SPECT and CT. . Thyroid, 2008;18(6): 663-664.
26、罗全勇#,王芳,张志勇,等.. 99mTc-HYNIC-Annexin B1的制备及其探测细胞凋亡的生物学评价. 中华核医学杂志,2008;28(4):217-222
27、罗全勇#,王芳,张志勇,等. . 99mTc-Annexin B1的制备及其的生物学评价. 中国医学影像技术,2008;24(8): 39-43.
28、罗全勇#,陈泽泉,王芳,等.. 99mTc-Annexin B1早期探测化疗后肿瘤细胞凋亡的实验研究. 中华肿瘤防治杂志,2008;15(20): 1524-1528.


版权所有 ? 2009 上海交通大学研究生院医学院分院上海市重庆南路227号 邮编:200025
电子邮件:yjsy@shsmu.edu.cn 总机:63846590
相关话题/导师 医学